Genome & Company is a global biopharmaceutical company that focuses on developing microbiome pharmaceuticals, consumer products, and novel immune checkpoint inhibitors. They are involved in the research and development of dietary supplements, cosmeceuticals, and new drugs utilizing the microbiome.
Focus Areas
Notable Investments
